Wittenberg Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-8,757
Closed -$271K 76
2020
Q1
$271K Sell
8,757
-959
-10% -$32.7K 0.15% 56
2019
Q4
$361K Sell
9,716
-479
-5% -$17.1K 0.14% 58
2019
Q3
$348K Sell
10,195
-480
-4% -$17.5K 0.15% 57
2019
Q2
$439K Sell
10,675
-850
-7% -$33.8K 0.19% 57
2019
Q1
$464K Hold
11,525
0.2% 57
2018
Q4
$477K Sell
11,525
-792
-6% -$32.9K 0.22% 54
2018
Q3
$515K Sell
12,317
-319
-3% -$12.3K 0.21% 53
2018
Q2
$435K Hold
12,636
0.18% 55
2018
Q1
$425K Sell
12,636
-1,054
-8% -$36.2K 0.18% 56
2017
Q4
$470K Sell
13,690
-161
-1% -$5.49K 0.2% 52
2017
Q3
$469K Sell
13,851
-642
-4% -$20.6K 0.2% 54
2017
Q2
$462K Buy
14,493
+243
+2% +$7.66K 0.21% 54
2017
Q1
$463K Hold
14,250
0.22% 51
2016
Q4
$439K Buy
+14,250
New +$435K 0.2% 58

Other funds holding PFE

Wittenberg Investment Management's PFE Position: Q2 2020 in Review

Wittenberg Investment Management sold out of Pfizer (PFE) in Q2 2020, closing a stake of 8,757 shares — an estimated $271K sold.

Wittenberg Investment Management first reported a position in PFE in Q4 2016 and held it in 14 quarters. The position peaked at $515K in Q3 2018. 2,443 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Wittenberg Investment Management reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
  • Wittenberg Investment Management sold 8,757 Pfizer shares in Q2 2020, an estimated $271K.
  • Wittenberg Investment Management first reported a position in Pfizer in Q4 2016 and held it in 14 quarters.
  • Wittenberg Investment Management's Pfizer position peaked at $515K in Q3 2018.
  • 2,443 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Wittenberg Investment Management's 13F filing for Q2 2020, filed 7 Aug 2020.